Page 34 - Journal of Structural Heart Disease Volume 5, Issue 2

47
Case Report
as a primary prevention of embolic stroke in the set- ting of a known IVC thrombus in a patient with RCC before radical nephrectomy. This case illustrates the complexity and the significance of proper planning and multidisciplinary discussion to provide the best treatment and care plan particularly in patients with a PFO and symptomatic severe AS.
This is an important viable approach particularly in tertiary and quaternary referral centers that take care of similar cases for optimizing patients with malig- nancy for major potentially curative surgeries given that about 25% of the US population has a PFO [12].
Acknowledgement
The authors would like to acknowledge Dr. Jen Chang from the Department of Anesthesiology at the University of Utah for providing her care during the PFO closure procedure along with TEE guidance.
Conflict of Interest
The authors have no conflict of interest relevant to this publication.
Comment on this Article or Ask a Question
References
1. Mas JL, Derumeaux G, Guillon B, Massardi- er E, Hosseini H, Mechtouff L, et al. CLOSE Investigators. Patent foramen ovale clo- sure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011– 1021. DOI: 10.1056/NEJMoa1705915.
2. Søndergaard L, Kasner SE, Rhodes JF, An- dersen G, Helle K. Iversen HK, Nielsen-Kud- sk JE, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033–1042. DOI: 10.1056/NEJMoa1707404.
3. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. On behalf of the RESPECT investigators. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-1032. DOI: 10.1056/ NEJMoa1610057.
4. Mojadidi MK, Elgendy AY, Elgendy IY, Mah- moud AN, Elbadawi A, Eshtehardi P, et al. Transcatheter patent foramen ovale clo- sure after cryptogenic stroke: an updated meta-analysis of randomized trials. J Am Coll Cardiol Intv. 2017;10:2228–2230. DOI: 10.1016/j.jcin.2017.09.002.
5. Fanari Z, Hammami S, Hopkins JT. Suc- cessful percutaneous transcatheter patent foramen ovale closure through the right internal jugular vein using stiff amplatzer catheter with a reshaped tip. Del Med J. 2016;88:238-241. PMID: 28751787.
6. Welgraz P, Konarska-Kuszewska E, Zebik T, Kuszewski P, Drzewiecka-Gerber A, Moty- ka M, et al. Transcatheter closure of patent foramen ovale using the internal jugular venous approach. Postepy Kardiol Inter- wencyjnej 2014;10:123-127. DOI: 10.5114/ pwki.2014.43520.
7. Psutka SP, Leibovich BC. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcino- ma. Ther Adv Urol. 2015;7:216-229. DOI: 10.1177/1756287215576443.
8. Tanaka M, Fujimoto K, Okajima E, Tanaka N, Yoshida K, Hirao Y. Prognostic factors of renal cell carcinoma with extension into in- ferior vena cava. Int J Urol. 2008;:394–398. DOI: 10.1111/j.1442-2042.2008.02017.x.
9. Nishimura RA, Otto CM, Bonow RO, Car- abello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the manage- ment of patients with valvular heart dis- ease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;129:2440-2492. DOI: 10.1161/CIR.0000000000000029.
10. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of val- vular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of
Cardiology (ESC) and the European Associ- ation for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2012;33:2451- 2496. DOI: 10.1714/1234.13659.
11. Epstein NE. Multidisciplinary in-hospi- tal teams improve patient outcomes: A review. Surg Neurol Int. 2014;5(Sup- plement 7):S295-S303. DOI: https://doi. org/10.4103/2152-7806.139612. eCollec- tion 2014.
12. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O’Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonog- raphy: the SPARC study. Stroke Preven- tion: Assessment of Risk in a Community. Mayo Clin Proce. 1999;74:862-869. PMID: 10488786.
Cite this article as: Al Danaf J, Saidi A, Smith B, Tandar A. Patent Foramen Ovale Closure using Cardioform Oc- cluder Device Through the Right Inter- nal Jugular Vein for Primary Prevention (First in Man): Importance of a Multi- disciplinary Team. Structural Heart Dis- ease. 2019;5(2):43-47. DOI: https://doi. org/10.12945/j.jshd.2019.019.18
Al Danaf J. et al.
PFO Closure for Primary Prevention